Evidence map›Paper›PMID 40253539›Full record

ArticleScientific reports2025

Development of paper based colorimetric method using pigment from red dragon fruit for determination of Cu and Fe.

Rimadani Pratiwi, Raspati Dewi Mulyaningsih, Aliya Nur Hasanah

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rimadani PratiwiDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Sumedang, 45363, Indonesia. rimadani.pratiwi@unpad.ac.id.
Raspati Dewi MulyaningsihMaster of Pharmacy Program, Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Sumedang, 45363, Indonesia.
Aliya Nur HasanahDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jalan Raya Bandung-Sumedang KM 21, Sumedang, 45363, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Betalain, a natural pigment found in red dragon fruit, has been proposed as a natural reagent for metal detection. In the present study, this pigment was extracted and used as a colorimetric reagent for Cu and Fe on a paper-based analytical device (PAD) and then applied to water samples. The extract was stable at 5 ± 3 °C for 16 weeks. In a solution with a pH of 4-5, the betalain extract changed color from pink to light orange (Cu) and yellow (Fe) and was selective against Na, K, Ca, Ba, Al, Mg, Zn, Hg, Ni, and Pb. The color change was caused by a metal-betalain complex with an estimated ratio of 1:2 (Cu-betalain) and 1:9 (Fe-betalain). Betalain PAD was produced under optimal conditions using Whatman CF1 paper containing 20 µL of 100 mg/mL betalain extract at pH 4-5. This process resulted in a limit of quantification of 3.133 mg/L (Cu) and 4.736 mg/L (Fe) and a limit of detection of 1.034 mg/L (Cu) and 1.563 mg/L (Fe). Based on these findings, betalain PAD made from red dragon fruit could be a viable alternative for the on-site detection of Cu and Fe in water. Ultimately, betalain PAD is a toxic waste-free, portable, fast, and prospective on-site tool for metal detection.

Indexed as

BetalainsCactaceaeColorimetryCopperFruitIronPaperPigments, BiologicalLimit of DetectionBetalainsCopperIronPigments, BiologicalBetalainColorimetric detectionCopperIronPaper analytical device

Identifiers

PMID40253539
PMCPMC12009377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.